Showing results (1691-1700 of 2,035) with videos related to
Sort By:
Pageof 204
Cancer Letters|January 15, 2019
Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8Shi Chen, Jiang-Zhi Chen, Jia-Qiang Zhang, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 24, 2022
Bevacizumab and atezolizumab as first-line therapy for advanced hepatocellular carcinoma: A Taiwanese subgroup analysis on efficacy and safetyYu-Yun Shao, Yin-Hsun Feng, Chia-Jui Yen, et al.Journal of Inorganic Biochemistry|June 7, 2020
A new Schiff base copper(II) complex induces cancer cell growth inhibition and apoptosis by multiple mechanismsRui-Dan Bao, Xue-Qing Song, Yan-Jie Kong, et al.Leukemia|November 17, 2025
Oncogenic activation of EVC/EVC2 defines a therapeutically targetable subset of acute myeloid leukemiaPinpin Sui, Ying Li, Juyeong Hong, et al.Surgical Endoscopy|March 15, 2025
Laparoscopic versus open secondary hepatectomy treating postoperative regional recurrent hepatolithiasis: a multicenter real-world studyDihang Wu, Long Huang, Chengyu Liao, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 3, 2024
Endo-Lysosomal Network Disorder Reprograms Energy Metabolism in SorL1-Null Rat HippocampusYajie Wang, Yuting Yang, Ying Cai, et al.World Journal of Pediatrics : WJP|October 21, 2023
Magnetic resonance imaging of knees: a novel approach to predict recombinant human growth hormone therapy response in short-stature children in late pubertyXi Bai, Zhi-Bo Zhou, Xiao-Yuan Guo, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|October 9, 2023
Blood Lipid Disorders in Post-Operative Craniopharyngioma Children and Adolescents and the Improvement with Recombinant Human Growth Hormone ReplacementHan-Ze Du, Kang Chen, Li-Yuan Zhang, et al.Oncotarget|February 28, 2018
Genetic correction improves prediction efficiency of serum tumor biomarkers on digestive cancer risk in the elderly Chinese cohort studyKe Wang, Yansen Bai, Shi Chen, et al.Frontiers in Immunology|December 20, 2021
A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor ActivitiesXiaopei Cui, Huifeng Jia, Hong Xin, et al.Pageof 204